- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Ischemia Reperfusion Injury Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Ischemia Reperfusion Injury Therapeutics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Clinic accounting for % of the Ischemia Reperfusion Injury Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While ANV-6L15 segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Ischemia Reperfusion Injury Therapeutics include Nyken B.V., Omeros Corporation, Opsona Therapeutics Limited, Orexo AB, and Pharming Group N.V., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ischemia Reperfusion Injury Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ANV-6L15
APP-103
BAY-606583
EP-80317
GS-459679
KN-93
LH-021
Others
Market segment by Application, can be divided into
Clinic
Hospital
Others
Market segment by players, this report covers
Nyken B.V.
Omeros Corporation
Opsona Therapeutics Limited
Orexo AB
Pharming Group N.V.
PledPharma AB
Prolong Pharmaceuticals
Proteo, Inc.
Prothix BV
Stealth BioTherapeutics Inc.
Zealand Pharma A/S
Amyndas Pharmaceuticals LLC
Angion Biomedica Corp.
Antipodean Pharmaceuticals, Inc.
Bayer AG
Biomedica Management Corporation
Bolder Biotechnology, Inc.
Curatis Pharma GmbH
Ensemble Therapeutics Corporation
Erimos Pharmaceuticals, LLC
Gilead Sciences, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Ischemia Reperfusion Injury Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Ischemia Reperfusion Injury Therapeutics, with revenue, gross margin and global market share of Ischemia Reperfusion Injury Therapeutics from 2019 to 2022.
Chapter 3, the Ischemia Reperfusion Injury Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Ischemia Reperfusion Injury Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Ischemia Reperfusion Injury Therapeutics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Ischemia Reperfusion Injury Therapeutics
1.2 Classification of Ischemia Reperfusion Injury Therapeutics by Type
1.2.1 Overview: Global Ischemia Reperfusion Injury Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Type in 2021
1.2.3 ANV-6L15
1.2.4 APP-103
1.2.5 BAY-606583
1.2.6 EP-80317
1.2.7 GS-459679
1.2.8 KN-93
1.2.9 LH-021
1.2.10 Others
1.3 Global Ischemia Reperfusion Injury Therapeutics Market by Application
1.3.1 Overview: Global Ischemia Reperfusion Injury Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Ischemia Reperfusion Injury Therapeutics Market Size & Forecast
1.5 Global Ischemia Reperfusion Injury Therapeutics Market Size and Forecast by Region
1.5.1 Global Ischemia Reperfusion Injury Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Ischemia Reperfusion Injury Therapeutics Market Size by Region, (2017-2022)
1.5.3 North America Ischemia Reperfusion Injury Therapeutics Market Size and Prospect (2017-2028)
1.5.4 Europe Ischemia Reperfusion Injury Therapeutics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size and Prospect (2017-2028)
1.5.6 South America Ischemia Reperfusion Injury Therapeutics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Ischemia Reperfusion Injury Therapeutics Market Drivers
1.6.2 Ischemia Reperfusion Injury Therapeutics Market Restraints
1.6.3 Ischemia Reperfusion Injury Therapeutics Trends Analysis
2 Company Profiles
2.1 Nyken B.V.
2.1.1 Nyken B.V. Details
2.1.2 Nyken B.V. Major Business
2.1.3 Nyken B.V. Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.1.4 Nyken B.V. Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Nyken B.V. Recent Developments and Future Plans
2.2 Omeros Corporation
2.2.1 Omeros Corporation Details
2.2.2 Omeros Corporation Major Business
2.2.3 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.2.4 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Omeros Corporation Recent Developments and Future Plans
2.3 Opsona Therapeutics Limited
2.3.1 Opsona Therapeutics Limited Details
2.3.2 Opsona Therapeutics Limited Major Business
2.3.3 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.3.4 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Opsona Therapeutics Limited Recent Developments and Future Plans
2.4 Orexo AB
2.4.1 Orexo AB Details
2.4.2 Orexo AB Major Business
2.4.3 Orexo AB Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.4.4 Orexo AB Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Orexo AB Recent Developments and Future Plans
2.5 Pharming Group N.V.
2.5.1 Pharming Group N.V. Details
2.5.2 Pharming Group N.V. Major Business
2.5.3 Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.5.4 Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Pharming Group N.V. Recent Developments and Future Plans
2.6 PledPharma AB
2.6.1 PledPharma AB Details
2.6.2 PledPharma AB Major Business
2.6.3 PledPharma AB Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.6.4 PledPharma AB Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 PledPharma AB Recent Developments and Future Plans
2.7 Prolong Pharmaceuticals
2.7.1 Prolong Pharmaceuticals Details
2.7.2 Prolong Pharmaceuticals Major Business
2.7.3 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.7.4 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Prolong Pharmaceuticals Recent Developments and Future Plans
2.8 Proteo, Inc.
2.8.1 Proteo, Inc. Details
2.8.2 Proteo, Inc. Major Business
2.8.3 Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.8.4 Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Proteo, Inc. Recent Developments and Future Plans
2.9 Prothix BV
2.9.1 Prothix BV Details
2.9.2 Prothix BV Major Business
2.9.3 Prothix BV Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.9.4 Prothix BV Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Prothix BV Recent Developments and Future Plans
2.10 Stealth BioTherapeutics Inc.
2.10.1 Stealth BioTherapeutics Inc. Details
2.10.2 Stealth BioTherapeutics Inc. Major Business
2.10.3 Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.10.4 Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Stealth BioTherapeutics Inc. Recent Developments and Future Plans
2.11 Zealand Pharma A/S
2.11.1 Zealand Pharma A/S Details
2.11.2 Zealand Pharma A/S Major Business
2.11.3 Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.11.4 Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Zealand Pharma A/S Recent Developments and Future Plans
2.12 Amyndas Pharmaceuticals LLC
2.12.1 Amyndas Pharmaceuticals LLC Details
2.12.2 Amyndas Pharmaceuticals LLC Major Business
2.12.3 Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.12.4 Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Amyndas Pharmaceuticals LLC Recent Developments and Future Plans
2.13 Angion Biomedica Corp.
2.13.1 Angion Biomedica Corp. Details
2.13.2 Angion Biomedica Corp. Major Business
2.13.3 Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.13.4 Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Angion Biomedica Corp. Recent Developments and Future Plans
2.14 Antipodean Pharmaceuticals, Inc.
2.14.1 Antipodean Pharmaceuticals, Inc. Details
2.14.2 Antipodean Pharmaceuticals, Inc. Major Business
2.14.3 Antipodean Pharmaceuticals, Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.14.4 Antipodean Pharmaceuticals, Inc. Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Antipodean Pharmaceuticals, Inc. Recent Developments and Future Plans
2.15 Bayer AG
2.15.1 Bayer AG Details
2.15.2 Bayer AG Major Business
2.15.3 Bayer AG Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.15.4 Bayer AG Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Bayer AG Recent Developments and Future Plans
2.16 Biomedica Management Corporation
2.16.1 Biomedica Management Corporation Details
2.16.2 Biomedica Management Corporation Major Business
2.16.3 Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.16.4 Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Biomedica Management Corporation Recent Developments and Future Plans
2.17 Bolder Biotechnology, Inc.
2.17.1 Bolder Biotechnology, Inc. Details
2.17.2 Bolder Biotechnology, Inc. Major Business
2.17.3 Bolder Biotechnology, Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.17.4 Bolder Biotechnology, Inc. Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Bolder Biotechnology, Inc. Recent Developments and Future Plans
2.18 Curatis Pharma GmbH
2.18.1 Curatis Pharma GmbH Details
2.18.2 Curatis Pharma GmbH Major Business
2.18.3 Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.18.4 Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Curatis Pharma GmbH Recent Developments and Future Plans
2.19 Ensemble Therapeutics Corporation
2.19.1 Ensemble Therapeutics Corporation Details
2.19.2 Ensemble Therapeutics Corporation Major Business
2.19.3 Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.19.4 Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Ensemble Therapeutics Corporation Recent Developments and Future Plans
2.20 Erimos Pharmaceuticals, LLC
2.20.1 Erimos Pharmaceuticals, LLC Details
2.20.2 Erimos Pharmaceuticals, LLC Major Business
2.20.3 Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.20.4 Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Erimos Pharmaceuticals, LLC Recent Developments and Future Plans
2.21 Gilead Sciences, Inc.
2.21.1 Gilead Sciences, Inc. Details
2.21.2 Gilead Sciences, Inc. Major Business
2.21.3 Gilead Sciences, Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
2.21.4 Gilead Sciences, Inc. Ischemia Reperfusion Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Gilead Sciences, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ischemia Reperfusion Injury Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Ischemia Reperfusion Injury Therapeutics Players Market Share in 2021
3.2.2 Top 10 Ischemia Reperfusion Injury Therapeutics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Ischemia Reperfusion Injury Therapeutics Players Head Office, Products and Services Provided
3.4 Ischemia Reperfusion Injury Therapeutics Mergers & Acquisitions
3.5 Ischemia Reperfusion Injury Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Ischemia Reperfusion Injury Therapeutics Revenue and Market Share by Type (2017-2022)
4.2 Global Ischemia Reperfusion Injury Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Application (2017-2022)
5.2 Global Ischemia Reperfusion Injury Therapeutics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2028)
6.2 North America Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2028)
6.3 North America Ischemia Reperfusion Injury Therapeutics Market Size by Country
6.3.1 North America Ischemia Reperfusion Injury Therapeutics Revenue by Country (2017-2028)
6.3.2 United States Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
6.3.3 Canada Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
6.3.4 Mexico Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2028)
7.2 Europe Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2028)
7.3 Europe Ischemia Reperfusion Injury Therapeutics Market Size by Country
7.3.1 Europe Ischemia Reperfusion Injury Therapeutics Revenue by Country (2017-2028)
7.3.2 Germany Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
7.3.3 France Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
7.3.5 Russia Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
7.3.6 Italy Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2028)
8.2 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2028)
8.3 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size by Region
8.3.1 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Region (2017-2028)
8.3.2 China Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
8.3.3 Japan Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
8.3.4 South Korea Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
8.3.5 India Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
8.3.7 Australia Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2028)
9.2 South America Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2028)
9.3 South America Ischemia Reperfusion Injury Therapeutics Market Size by Country
9.3.1 South America Ischemia Reperfusion Injury Therapeutics Revenue by Country (2017-2028)
9.3.2 Brazil Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
9.3.3 Argentina Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2028)
10.2 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2028)
10.3 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size by Country
10.3.1 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue by Country (2017-2028)
10.3.2 Turkey Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
10.3.4 UAE Ischemia Reperfusion Injury Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Ischemia Reperfusion Injury Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Ischemia Reperfusion Injury Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Ischemia Reperfusion Injury Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Ischemia Reperfusion Injury Therapeutics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Region (2023-2028)
Table 6. Nyken B.V. Corporate Information, Head Office, and Major Competitors
Table 7. Nyken B.V. Major Business
Table 8. Nyken B.V. Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 9. Nyken B.V. Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Omeros Corporation Corporate Information, Head Office, and Major Competitors
Table 11. Omeros Corporation Major Business
Table 12. Omeros Corporation Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 13. Omeros Corporation Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Opsona Therapeutics Limited Corporate Information, Head Office, and Major Competitors
Table 15. Opsona Therapeutics Limited Major Business
Table 16. Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 17. Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Orexo AB Corporate Information, Head Office, and Major Competitors
Table 19. Orexo AB Major Business
Table 20. Orexo AB Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 21. Orexo AB Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pharming Group N.V. Corporate Information, Head Office, and Major Competitors
Table 23. Pharming Group N.V. Major Business
Table 24. Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 25. Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. PledPharma AB Corporate Information, Head Office, and Major Competitors
Table 27. PledPharma AB Major Business
Table 28. PledPharma AB Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 29. PledPharma AB Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Prolong Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Prolong Pharmaceuticals Major Business
Table 32. Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 33. Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Proteo, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Proteo, Inc. Major Business
Table 36. Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 37. Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Prothix BV Corporate Information, Head Office, and Major Competitors
Table 39. Prothix BV Major Business
Table 40. Prothix BV Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 41. Prothix BV Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Stealth BioTherapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Stealth BioTherapeutics Inc. Major Business
Table 44. Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 45. Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Zealand Pharma A/S Corporate Information, Head Office, and Major Competitors
Table 47. Zealand Pharma A/S Major Business
Table 48. Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 49. Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Amyndas Pharmaceuticals LLC Corporate Information, Head Office, and Major Competitors
Table 51. Amyndas Pharmaceuticals LLC Major Business
Table 52. Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 53. Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Angion Biomedica Corp. Corporate Information, Head Office, and Major Competitors
Table 55. Angion Biomedica Corp. Major Business
Table 56. Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 57. Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Antipodean Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 59. Antipodean Pharmaceuticals, Inc. Major Business
Table 60. Antipodean Pharmaceuticals, Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 61. Antipodean Pharmaceuticals, Inc. Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 63. Bayer AG Major Business
Table 64. Bayer AG Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 65. Bayer AG Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Biomedica Management Corporation Corporate Information, Head Office, and Major Competitors
Table 67. Biomedica Management Corporation Major Business
Table 68. Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 69. Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Bolder Biotechnology, Inc. Corporate Information, Head Office, and Major Competitors
Table 71. Bolder Biotechnology, Inc. Major Business
Table 72. Bolder Biotechnology, Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 73. Bolder Biotechnology, Inc. Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Curatis Pharma GmbH Corporate Information, Head Office, and Major Competitors
Table 75. Curatis Pharma GmbH Major Business
Table 76. Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 77. Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Ensemble Therapeutics Corporation Corporate Information, Head Office, and Major Competitors
Table 79. Ensemble Therapeutics Corporation Major Business
Table 80. Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 81. Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Erimos Pharmaceuticals, LLC Corporate Information, Head Office, and Major Competitors
Table 83. Erimos Pharmaceuticals, LLC Major Business
Table 84. Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 85. Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Gilead Sciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 87. Gilead Sciences, Inc. Major Business
Table 88. Gilead Sciences, Inc. Ischemia Reperfusion Injury Therapeutics Product and Solutions
Table 89. Gilead Sciences, Inc. Ischemia Reperfusion Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Global Ischemia Reperfusion Injury Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 91. Global Ischemia Reperfusion Injury Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 92. Breakdown of Ischemia Reperfusion Injury Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Ischemia Reperfusion Injury Therapeutics Players Head Office, Products and Services Provided
Table 94. Ischemia Reperfusion Injury Therapeutics Mergers & Acquisitions in the Past Five Years
Table 95. Ischemia Reperfusion Injury Therapeutics New Entrants and Expansion Plans
Table 96. Global Ischemia Reperfusion Injury Therapeutics Revenue (USD Million) by Type (2017-2022)
Table 97. Global Ischemia Reperfusion Injury Therapeutics Revenue Share by Type (2017-2022)
Table 98. Global Ischemia Reperfusion Injury Therapeutics Revenue Forecast by Type (2023-2028)
Table 99. Global Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2022)
Table 100. Global Ischemia Reperfusion Injury Therapeutics Revenue Forecast by Application (2023-2028)
Table 101. North America Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 102. North America Ischemia Reperfusion Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 103. North America Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 104. North America Ischemia Reperfusion Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 105. North America Ischemia Reperfusion Injury Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 106. North America Ischemia Reperfusion Injury Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 107. Europe Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 108. Europe Ischemia Reperfusion Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 109. Europe Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 110. Europe Ischemia Reperfusion Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 111. Europe Ischemia Reperfusion Injury Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 112. Europe Ischemia Reperfusion Injury Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 113. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 114. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 115. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 116. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 117. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 118. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 119. South America Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 120. South America Ischemia Reperfusion Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 121. South America Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 122. South America Ischemia Reperfusion Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 123. South America Ischemia Reperfusion Injury Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 124. South America Ischemia Reperfusion Injury Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 125. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 126. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 127. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 128. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 129. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 130. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Ischemia Reperfusion Injury Therapeutics Picture
Figure 2. Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Type in 2021
Figure 3. ANV-6L15
Figure 4. APP-103
Figure 5. BAY-606583
Figure 6. EP-80317
Figure 7. GS-459679
Figure 8. KN-93
Figure 9. LH-021
Figure 10. Others
Figure 11. Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Application in 2021
Figure 12. Clinic Picture
Figure 13. Hospital Picture
Figure 14. Others Picture
Figure 15. Global Ischemia Reperfusion Injury Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global Ischemia Reperfusion Injury Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Region (2017-2028)
Figure 18. Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Region in 2021
Figure 19. North America Ischemia Reperfusion Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe Ischemia Reperfusion Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America Ischemia Reperfusion Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa Ischemia Reperfusion Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Ischemia Reperfusion Injury Therapeutics Market Drivers
Figure 25. Ischemia Reperfusion Injury Therapeutics Market Restraints
Figure 26. Ischemia Reperfusion Injury Therapeutics Market Trends
Figure 27. Nyken B.V. Recent Developments and Future Plans
Figure 28. Omeros Corporation Recent Developments and Future Plans
Figure 29. Opsona Therapeutics Limited Recent Developments and Future Plans
Figure 30. Orexo AB Recent Developments and Future Plans
Figure 31. Pharming Group N.V. Recent Developments and Future Plans
Figure 32. PledPharma AB Recent Developments and Future Plans
Figure 33. Prolong Pharmaceuticals Recent Developments and Future Plans
Figure 34. Proteo, Inc. Recent Developments and Future Plans
Figure 35. Prothix BV Recent Developments and Future Plans
Figure 36. Stealth BioTherapeutics Inc. Recent Developments and Future Plans
Figure 37. Zealand Pharma A/S Recent Developments and Future Plans
Figure 38. Amyndas Pharmaceuticals LLC Recent Developments and Future Plans
Figure 39. Angion Biomedica Corp. Recent Developments and Future Plans
Figure 40. Antipodean Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 41. Bayer AG Recent Developments and Future Plans
Figure 42. Biomedica Management Corporation Recent Developments and Future Plans
Figure 43. Bolder Biotechnology, Inc. Recent Developments and Future Plans
Figure 44. Curatis Pharma GmbH Recent Developments and Future Plans
Figure 45. Ensemble Therapeutics Corporation Recent Developments and Future Plans
Figure 46. Erimos Pharmaceuticals, LLC Recent Developments and Future Plans
Figure 47. Gilead Sciences, Inc. Recent Developments and Future Plans
Figure 48. Global Ischemia Reperfusion Injury Therapeutics Revenue Share by Players in 2021
Figure 49. Ischemia Reperfusion Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 50. Global Top 3 Players Ischemia Reperfusion Injury Therapeutics Revenue Market Share in 2021
Figure 51. Global Top 10 Players Ischemia Reperfusion Injury Therapeutics Revenue Market Share in 2021
Figure 52. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 53. Global Ischemia Reperfusion Injury Therapeutics Revenue Share by Type in 2021
Figure 54. Global Ischemia Reperfusion Injury Therapeutics Market Share Forecast by Type (2023-2028)
Figure 55. Global Ischemia Reperfusion Injury Therapeutics Revenue Share by Application in 2021
Figure 56. Global Ischemia Reperfusion Injury Therapeutics Market Share Forecast by Application (2023-2028)
Figure 57. North America Ischemia Reperfusion Injury Therapeutics Sales Market Share by Type (2017-2028)
Figure 58. North America Ischemia Reperfusion Injury Therapeutics Sales Market Share by Application (2017-2028)
Figure 59. North America Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Country (2017-2028)
Figure 60. United States Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Canada Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Mexico Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Europe Ischemia Reperfusion Injury Therapeutics Sales Market Share by Type (2017-2028)
Figure 64. Europe Ischemia Reperfusion Injury Therapeutics Sales Market Share by Application (2017-2028)
Figure 65. Europe Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Country (2017-2028)
Figure 66. Germany Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. France Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. United Kingdom Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Russia Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Italy Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Sales Market Share by Type (2017-2028)
Figure 72. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Sales Market Share by Application (2017-2028)
Figure 73. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Region (2017-2028)
Figure 74. China Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Japan Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Korea Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. India Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Southeast Asia Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Australia Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South America Ischemia Reperfusion Injury Therapeutics Sales Market Share by Type (2017-2028)
Figure 81. South America Ischemia Reperfusion Injury Therapeutics Sales Market Share by Application (2017-2028)
Figure 82. South America Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Country (2017-2028)
Figure 83. Brazil Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Argentina Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Middle East and Africa Ischemia Reperfusion Injury Therapeutics Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Ischemia Reperfusion Injury Therapeutics Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Country (2017-2028)
Figure 88. Turkey Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 89. Saudi Arabia Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 90. UAE Ischemia Reperfusion Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 91. Methodology
Figure 92. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
